Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-11 5:04 pm Sale | 13G | DYNE THERAPEUTICS INC DYN | Atlas Venture Fund XI L.P. | 7,326,117 14.2% | -814,013 (-10.00%) | View |
2022-02-04 09:17 am Sale | 13G | DYNE THERAPEUTICS INC DYN | WELLINGTON MANAGEMENT GROUP LLP | 1,763,053 3.42% | -1,141,669 (-39.30%) | View |
2022-01-20 4:27 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital LP | 2,816,950 5.47% | 2,816,950 (New Position) | View |
2021-08-16 2:37 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | Logos Global Management LP | 3,894,392 7.6% | 3,894,392 (New Position) | View |
2021-02-16 5:28 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | Atlas Venture Fund XI L.P. | 8,140,130 17.9% | 8,140,130 (New Position) | View |
2021-02-16 4:39 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | RA CAPITAL MANAGEMENT L.P. | 2,805,045 6.2% | 2,805,045 (New Position) | View |
2021-02-16 4:30 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | CITADEL ADVISORS LLC | 3,164,401 7% | 218,450 (+7.42%) | View |
2021-02-16 06:38 am Purchase | 13G | DYNE THERAPEUTICS INC DYN | Forbion Capital Fund IV Cooperatief U.A. | 6,131,079 13.49% | 6,131,079 (New Position) | View |
2021-02-12 4:24 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | MPM BIOVENTURES 2018 L.P. | 4,951,303 10.9% | 4,951,303 (New Position) | View |
2021-02-03 3:11 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | WELLINGTON MANAGEMENT GROUP LLP | 2,904,722 6.39% | 2,904,722 (New Position) | View |
2020-10-01 4:41 pm Purchase | 13D | DYNE THERAPEUTICS INC DYN | Vida Ventures II LLC | 2,960,046 6.5% | 2,960,046 (New Position) | View |
2020-09-28 4:03 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | CITADEL ADVISORS LLC | 2,945,951 6.5% | 2,945,951 (New Position) | View |